Issue Date: August 8, 2016
Celanese has ceased making monomethylamine in Cangrejera, Mexico, after a review determined that continued production was no longer a “viable business option.” The company has redirected monomethylamine equipment towards dimethylamine and trimethylamine.
The Chemical Heritage Foundationhas named former British Museum director Robert Anderson as its interim president. Predecessor Carsten Reinhardt, who headed CHF since 2013, is returning to Germany and will be a history of science professor at Bielefeld University.
Sumitomo Chemical and Zeon Corp. are studying the combination of their solution styrene-butadiene rubber businesses. A joint venture, the Japanese companies say, would accelerate new product development and enhance cost competitiveness.
JSR will sell its line of Opstar coating materials, used primarily to impart anti-reflective properties to liquid crystal displays, to Arakawa Chemical Industries. The business has been struggling due to poor market conditions, JSR says.
Avrobio has raised $25 million in its first formal round of funding. The cash will be used to advance gene therapies for Fabry disease and acute myeloid leukemia. Avrobio inserts a new, functional copy of a faulty gene into a patient’s own stem cells, which are then given back to the patient.
Evelo Biosciences will work with Mayo Clinic researchers on microbiome-based therapies for cancer. Using samples from patients, the partners will isolate and characterize cancer-associated bacteria that might be used to activate the immune system against cancer. Mayo Clinic has a financial interest in Evelo.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society